Analyst Coverage

Andy D’Silva
B. Riley FBR

Cumberland Pharmaceuticals, Inc. is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Cumberland Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Cumberland Pharmaceuticals, Inc. or its management. Cumberland Pharmaceuticals, Inc. does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.